Publication | Closed Access
Double-Blind, Randomized, Placebo-Controlled, Dose-Response Study of the Safety and Efficacy of Botulinum Toxin Type A in Subjects with Crow's Feet
123
Citations
9
References
2006
Year
BTX-A is safe and effective in decreasing the severity of crow's feet, with 12 U per side suggested as the most appropriate dose.
| Year | Citations | |
|---|---|---|
Page 1
Page 1